S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
Free Trial
OTCMKTS:TSOI

Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free TSOI Stock Alerts
$0.0007
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.0007
▼
$0.0008
50-Day Range
N/A
52-Week Range
$0.0006
▼
$0.0063
Volume
32.69 million shs
Average Volume
16.22 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest
TSOI stock logo

About Therapeutic Solutions International Stock (OTCMKTS:TSOI)

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.

TSOI Stock Price History

TSOI Stock News Headlines

April 14, 2024 | finance.yahoo.com
Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority
April 11, 2024 | americanbankingnews.com
Short Interest in Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Drops By 45.4%
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
April 11, 2024 | americanbankingnews.com
Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update
April 8, 2024 | usnews.com
Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
April 8, 2024 | finance.yahoo.com
Therapeutic Solutions International, Inc. (TSOI)
April 2, 2024 | finance.yahoo.com
Kelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo CAR-T Cell Therapy in Multiple Myeloma
April 2, 2024 | finance.yahoo.com
Therapeutic mRNA Patent Monitoring Service 2024: Track Competitors' IP Activities and their Future Intentions
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 18, 2024 | msn.com
Aveeno Therapeutic Shave Gel with Oat and Vitamin E to Help Prevent Razor Bumps, Now 24% Off
March 11, 2024 | msn.com
Rising Stars Therapeutic Riding Center: Cowgirl Bunco night coming soon
March 11, 2024 | finance.yahoo.com
Arthritic Therapeutic Market to Reach $ 136.1 billion, Globally, by 2032 at 5.5% CAGR: Allied Market Research
March 4, 2024 | finance.yahoo.com
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
February 29, 2024 | finance.yahoo.com
Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
February 26, 2024 | finance.yahoo.com
Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation
February 26, 2024 | businesswire.com
Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation
February 23, 2024 | benzinga.com
Therapeutic Solns Intl Stock (OTC:TSOI), Analyst Ratings, Price Targets, Predictions
February 20, 2024 | finance.yahoo.com
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
February 18, 2024 | msn.com
Patient safety advocate 'horrified' at government's plans to drop Therapeutic Products Act
February 6, 2024 | finance.yahoo.com
Peptide Therapeutics Market Surges Towards USD 101.7 Billion by 2033 | Analyzing Growth in Therapeutic Innovations and Disease Management
February 1, 2024 | msn.com
Cosmetic injectables industry slams crackdown on advertising rules by Therapeutic Goods Administration
January 31, 2024 | finance.yahoo.com
APAC Epilepsy Therapeutic Market Poised for Growth, Set to Expand by USD 449.35 Mn through 2023-2028
January 22, 2024 | finance.yahoo.com
Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
January 3, 2024 | finance.yahoo.com
Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™
December 11, 2023 | finance.yahoo.com
Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
November 27, 2023 | finance.yahoo.com
Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression
November 20, 2023 | finance.yahoo.com
Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA
See More Headlines
Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/16/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:TSOI
CUSIP
883378101
CIK
1419051
Web
therapeuticsolutionsint.com
Phone
(760) 295-7208
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Timothy George Dixon (Age 66)
    Chairman, CEO, President & CFO
    Comp: $240k
  • Dr. Feng Lin M.D. (Age 53)
    Ph.D., Chief Scientific Officer
  • Dr. James Drew Veltmeyer M.D. (Age 58)
    Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board
  • Ms. Famela Ramos (Age 47)
    Vice President of Business Development
  • Ms. Serena Robella
    Director of Sales

Key Competitors

View All Competitors

TSOI Stock Analysis - Frequently Asked Questions

How have TSOI shares performed in 2024?

Therapeutic Solutions International's stock was trading at $0.0010 on January 1st, 2024. Since then, TSOI shares have decreased by 30.0% and is now trading at $0.0007.
View the best growth stocks for 2024 here.

Are investors shorting Therapeutic Solutions International?

Therapeutic Solutions International saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 148,600 shares, a decrease of 45.4% from the March 15th total of 272,300 shares. Based on an average trading volume of 39,779,500 shares, the short-interest ratio is currently 0.0 days.
View Therapeutic Solutions International's Short Interest.

When is Therapeutic Solutions International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 16th 2024.
View our TSOI earnings forecast.

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD).

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TSOI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends